Literature DB >> 1086736

Tuberculin sensitivity in guinea-pigs after vaccination with varying doses of BCG of 12 different strains.

A Ladefoged, K Bunch-Christensen, J Guld.   

Abstract

In several previously reported studies a number of BCG strains, including those most widely used in vaccine production, were ranked according to their in vivo activity in various experimental models in rodents and to the local and allergic response that they provoked in children. In this report, 12 strains are ranked in terms of tuberculin conversion in guinea-pigs according to the minimum sensitizing dose. For 10 of these strains, this minimum dose is very low, ranging from 5 to 50 culturable particles. Thus the traditional practice of tuberculin-testing guinea-pigs that have been vaccinated with a full human dose of BCG (of the order of one million culturable particles) has such a low discriminating power that it is useless as a routine test for currently used vaccines. The ranking obtained in this model was largely but not completely in accordance with similar rankings in other models. The Tokyo strain and, to some extent, the London strain ranked comparatively lower than they do in children. The pronounced lack of virulence of the Prague strain was confirmed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086736      PMCID: PMC2366516     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  THE ACQUIRED RESISTANCE TO TUBERCULOSIS INDUCED BY BCG VACCINE ASSAYED BY A QUANTITATIVE METHOD ON RED MICE. CLETHRIONOMYS G. GLAREOLUS SCHREB. II. VACCINATION EFFECT OF BCG STRAINS STRONGLY OR MODERATELY VIRULENT FOR HAMSTERS.

Authors:  A JESPERSEN; M W BENTZON
Journal:  Acta Tuberc Pneumol Scand       Date:  1964

2.  The heterogeneity of BCG.

Authors:  S WILLIS; M VANDIVIERE
Journal:  Am Rev Respir Dis       Date:  1961-08

3.  Differential characteristics in vitro and in vivo of several substrains of BCG. IV. Immunizing effectiveness.

Authors:  R J DUBOS; C H PIERCE
Journal:  Am Rev Tuberc       Date:  1956-11

4.  Studies on tuberculin sensitivity and immunity in guinea-pigs induced by vaccination with varying doses of BCG vaccine.

Authors:  A JESPERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1956

5.  Antituberculous immunity induced in red mice (Clethrionomys G. glareolus Schreb.) by vaccination with living BCG.

Authors:  A JESPERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1954

6.  Tuberculin sensitivity and skin lesions in children after vaccination with 11 different BCG strains.

Authors:  R S Vallishayee; A N Shashidhara; K Bunch-Christensen; J Guld
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

7.  Some evidence of the efficacy of mass BCG vaccination.

Authors:  K Bjartveit; H Waaler
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

8.  The virulence of some strains of BCG for golden hamsters.

Authors:  K Bunch-Christensen; A Ladefoged; J Guld
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  8 in total
  10 in total

Review 1.  Immunity to tuberculosis from the perspective of pathogenesis.

Authors:  E Wiegeshaus; V Balasubramanian; D W Smith
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

Review 2.  Inhaled drug delivery for tuberculosis therapy.

Authors:  Pavan Muttil; Chenchen Wang; Anthony J Hickey
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

3.  Cell-mediated immunity in malnourished guinea pigs after Mycobacterium bovis BCG vaccination.

Authors:  D N McMurray; E A Yetley
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

4.  Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur.

Authors:  Marcia Berrêdo-Pinho; Dario E Kalume; Paloma R Correa; Leonardo H F Gomes; Melissa P Pereira; Renata F da Silva; Luiz R R Castello-Branco; Wim M Degrave; Leila Mendonça-Lima
Journal:  BMC Microbiol       Date:  2011-04-20       Impact factor: 3.605

5.  A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence.

Authors:  Carolyn M Shoen; Michelle S DeStefano; Cynthia C Hager; Kyi-Toe Tham; Miriam Braunstein; Alexandria D Allen; Hiriam O Gates; Michael H Cynamon; Douglas S Kernodle
Journal:  Vaccines (Basel)       Date:  2013-01-11

6.  Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.

Authors:  Shanmugalakshmi Sadagopal; Miriam Braunstein; Cynthia C Hager; Jie Wei; Alexandria K Daniel; Markian R Bochan; Ian Crozier; Nathaniel E Smith; Hiriam O Gates; Louise Barnett; Luc Van Kaer; James O Price; Timothy S Blackwell; Spyros A Kalams; Douglas S Kernodle
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

7.  Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.

Authors:  Andrea S Leung; Vanessa Tran; Zuowei Wu; Xuping Yu; David C Alexander; George Fu Gao; Baoli Zhu; Jun Liu
Journal:  BMC Genomics       Date:  2008-09-15       Impact factor: 3.969

8.  Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms.

Authors:  Lu Zhang; Huan-Wei Ru; Fu-Zeng Chen; Chun-Yan Jin; Rui-Feng Sun; Xiao-Yong Fan; Ming Guo; Jun-Tao Mai; Wen-Xi Xu; Qing-Xia Lin; Jun Liu
Journal:  Mol Ther       Date:  2015-12-08       Impact factor: 11.454

9.  Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis.

Authors:  Sang Kyun Ahn; Vanessa Tran; Andrea Leung; Mark Ng; Ming Li; Jun Liu
Journal:  Mol Ther       Date:  2018-09-01       Impact factor: 11.454

10.  Is BCG vaccination causally related to reduced COVID-19 mortality?

Authors:  Masayuki Miyasaka
Journal:  EMBO Mol Med       Date:  2020-05-26       Impact factor: 12.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.